Europese Unie - Nederlands - EMA (European Medicines Agency)

adienne s.r.l. s.u. - thiotepa - hematopoietische stamceltransplantatie - antineoplastische middelen - in combinatie met andere chemotherapeutische geneesmiddelen:met of zonder total body bestraling (tbi), airconditioning behandeling voorafgaand aan allogene of autologe hematopoïetische progenitor cel transplantatie (hpct) in hematologische aandoeningen bij volwassen en pediatrische patiënten;bij hoge dosis chemotherapie met hpct steun is geschikt voor de behandeling van vaste tumoren bij volwassen en pediatrische patiënten. er wordt voorgesteld dat tepadina moet worden voorgeschreven door artsen met ervaring in airconditioning behandeling voorafgaand aan de hematopoëtische progenitor cel transplantatie.

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

hospira benelux bvba pleinlaan 17 1050 brussel (belgiË) - aciclovir natrium samenstelling overeenkomend met ; ; aciclovir 25 mg/ml - concentraat voor oplossing voor infusie - natriumhydroxide (e 524) ; stikstof (head space) (e 941) ; water voor injectie ; zoutzuur (e 507), - aciclovir

Europese Unie - Nederlands - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfoom, mantel-cel - antineoplastische middelen - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Europese Unie - Nederlands - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastische middelen - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Europese Unie - Nederlands - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - antineoplastische middelen - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Europese Unie - Nederlands - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastische middelen - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

thiotepa 100 mg/flacon - poeder voor concentraat voor oplossing voor infusie - stikstof (head space) (e 941)

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

thiotepa 15 mg/flacon - poeder voor concentraat voor oplossing voor infusie - stikstof (head space) (e 941)

Europese Unie - Nederlands - EMA (European Medicines Agency)

gentium s.r.l. - defibrotide - hepatische veno-occlusieve ziekte - antitrombotische middelen - defitelio is geïndiceerd voor de behandeling van ernstige hepatische veno-occlusieve aandoening (vod), ook bekend als sinusoïdaal obstructief syndroom (sos) bij hematopoëtische stamceltransplantatie (hsct) therapie.. het is geïndiceerd bij volwassenen en adolescenten, kinderen en baby ' s gedurende 1 maand oud.

Europese Unie - Nederlands - EMA (European Medicines Agency)

lipomed gmbh - cladribine - leukemie, harige cel - antineoplastische middelen - litak is geïndiceerd voor de behandeling van haarcelleukemie.